Alex Hoffman / endpoints - → In what appears to be another blow to Novo Nordisk, ex-Pfizer CSO Mikael Dolsten has withdrawn his nomination to join the company's board of directors due to ...
#healthcare #pharmaceuticals #publichealth #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, November 15, 2025, 3:21 pm / permalink 16003 / 2 stories in 4 months
EPA proposes rollback on ethylene oxide sterilizer emissions (30 min)
Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.